Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants
Journal of Allergy and Clinical Immunology · 2025-01 · 155 (1) · 166-175
DOI: 10.1016/j.jaci.2024.08.014 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Allergy and Clinical Immunology, 2025-01. Verfasst von Ines Santisteban und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC. Hauptthemen laut MEDLINE: Adenosine Deaminase, Mutation, Missense, Genotype, Agammaglobulinemia. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 43 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Institute of Health, Enzon Pharmaceuticals Inc, Leadiant Biosciences Inc.
Abstract (Originalsprache)
Kein Abstract verfügbar.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC.
- Department of Chemistry, Vanderbilt University, Nashville, Tenn.
- Department of Biological Sciences, Vanderbilt University, Nashville, Tenn.
- Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC; Department of Medicine, Veterans Affairs Medical Center, Durham, NC.
- Department of Medicine, Division of Rheumatology and Immunology, Duke University School of Medicine, Durham, NC; Department of Biochemistry, Duke University School of Medicine, Durham, NC. Electronic address: michael.he…
Förderung
- National Institute of Health
- Enzon Pharmaceuticals Inc
- Leadiant Biosciences Inc
- Chiesi USA Inc
Zitieren
APA
Santisteban, I., Arredondo-Vega, F. X., Bali, P., Dalgic, B., Lee, H. H., Kim, M., Hermanson, J., Tarrant, T. K., & Hershfield, M. S. (2025). Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants. Journal of Allergy and Clinical Immunology, 155(1), 166-175. https://doi.org/10.1016/j.jaci.2024.08.014
Vancouver
Santisteban I, Arredondo-Vega FX, Bali P, Dalgic B, Lee HH, Kim M, et al. Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants. Journal of Allergy and Clinical Immunology. 2025;155(1):166-175. doi:10.1016/j.jaci.2024.08.014
BibTeX
@article{Santisteban2025,
author = {Santisteban, Ines and Arredondo-Vega, Francisco X and Bali, Pawan and Dalgic, Busra and Lee, Hyun Ho and Kim, Minsoo and Hermanson, Jake and Tarrant, Teresa K and Hershfield, Michael S},
title = {Evolving spectrum of adenosine deaminase (ADA) deficiency: Assessing genotype pathogenicity according to expressed ADA activity of 46 variants},
journal = {Journal of Allergy and Clinical Immunology},
year = {2025},
volume = {155},
number = {1},
pages = {166--175},
doi = {10.1016/j.jaci.2024.08.014}
}
EUVIMED